Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment. Heraud C, Bresch S, Bourg V, Landes-Chateau C, et al. J Neurol 2025;272:451.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Heraud C, Bresch S, Bourg V, Landes-Chateau C, et al. Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment. J Neurol 2025;272:451.
PMID: 40488894